NEW YORK, NY / ACCESS Newswire / June 8, 2026 / A new economic reality is reshaping global manufacturing, and it is challenging one of the oldest assumptions in the ...
Incyte (Nasdaq:INCY) announced today it has entered into a definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned subsidiary of Star Therapeutics, LLC, for $1.25 billion. Star ...